As new CAR T-cell therapies are being approved to treat certain cancers, Ankit Kansagra, M.D., explains how the UT Southwestern team is working to further revolutionize treatment for more cancer patients.
A new, FDA-approved four-drug combo for AL amyloidosis is improving longevity and quality of life dramatically. Ankit Kansagra, M.D., discusses how the medication and a multidisciplinary team of experts can give patients longer, healthier lives.
